Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v3.7.0.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Cash Flows from Operating Activities:    
Net Loss $ (2,567,779) $ (2,832,669)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization of Film and Television Costs 8,086 135,157
Depreciation Expense 33,865 33,063
Amortization Expense 31,012 38,315
Imputed Interest Expense 0 6,141
Stock Issued for Services 100,000 24,000
Stock Compensation Expense 405,633 877,962
Gain on Distribution Contracts 0 (258,103)
Loss on Impairment of Assets 0 1,850
Decrease (Increase) in Operating Assets    
Accounts Receivable (181,481) 79,503
Inventory (13,318) 518
Prepaid Expenses & Other Assets (21,600) (145,634)
Film and Television Costs, net (1,473,384) (381,963)
Increase (Decrease) in Operating Liabilities    
Accounts Payable (345,900) 133,069
Accrued Salaries 32,717 20,000
Deferred Revenue and Advances 424,313 2,140,369
Other Accrued Expenses 9,198 (195,786)
Net Cash Used in Operating Activities (3,558,638) (324,208)
Cash Flows from Investing Activities:    
Investment in Intangible Assets 0 (5,650)
Investment in Fixed Assets (29,407) (1,542)
Net Cash Used in Investing Activities (29,407) (7,192)
Cash Flows from Financing Activities:    
Proceeds from Warrant Exchange, Net of Offering Costs 3,401,924 0
Proceeds from Exercise of Warrants 0 82,500
Proceeds from Production Facility, Net 1,284,728 0
Net cash provided by financing activities 4,686,652 82,500
Net Increase (Decrease) in Cash, Cash Equivalents, and Restricted Cash 1,098,607 (248,900)
Beginning Cash, Cash Equivalents, and Restricted Cash 2,887,921 5,187,620
Ending Cash, Cash Equivalents, and Restricted Cash 3,986,528 4,938,720
Supplemental Disclosures of Cash Flow Information:    
Cash paid for interest 2,033 507
Schedule of non-cash financing and investing activites:    
Issuance of Common Stock in Relation to Sony Transaction 1,489,583 0
Issuance of Common Stock in Satisfaction of Short Term Advances $ 0 $ 410,535